Drug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption

AbstractPurpose. Appropriate physicochemical parameters are desired for the prediction of passive intestinal drug absorption during lead compound selection and drug development. Methods. Liposome distribution coefficients measured titrimetrically and solubility data at pH 6.8 were used to characterize 21 structurally diverse ionizable drugs covering a range from <5% to almost complete absorption. Results. A sigmoidal relationship was found between the percentage of human passive intestinal absorption and a new absorption potential parameter calculated from liposome distribution data and the solubility dose ratio. In contrast, the human absorption data did not correlate with an octanol-based absorption potential or partitioning data alone. Poor correlations were found between liposome and octanol partitioning of ionic species or nonionic bases indicating the profound differences of the partitioning systems. Conclusions. Liposome distribution coefficients of ionizable drugs derived by a pH-metric titration were successfully used to calculate a parameter that correlates with the percentage of passive intestinal absorption in humans. Profound differences between liposome and octanol partitioning were found for a highly diverse set of species. This titration technique may serve to generate liposome partitioning data for the selection and optimization of lead compounds and in drug development.

[1]  Shiyin Yee,et al.  In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.

[2]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[3]  K. Lauritsen,et al.  Clinical pharmacolinetics of drugs used in the treatment of gastrointestinal diseases. I , 1990 .

[4]  B. Brodie,et al.  The gastric secretion of drugs: a pH partition hypothesis. , 1957, The Journal of pharmacology and experimental therapeutics.

[5]  J. Jensen,et al.  Clinical pharmacokinetics of terbinafine (Lamisil) , 1989, Clinical and experimental dermatology.

[6]  P. Routledge,et al.  Clinical Pharmacokinetics of Propranolol , 1979, Clinical pharmacokinetics.

[7]  L. S. Wan,et al.  CMC of polysorbates. , 1974, Journal of pharmaceutical sciences.

[8]  J. Rask-Madsen,et al.  Clinical Pharmacokinetics of Drugs Used in the Treatment of Gastrointestinal Diseases (Part I) , 1990, Clinical pharmacokinetics.

[9]  P. de Miranda,et al.  Pharmacokinetics of acyclovir after intravenous and oral administration. , 1983, The Journal of antimicrobial chemotherapy.

[10]  P. Finholt,et al.  Dissolution kinetics of drugs in human gastric juice--the role of surface tension. , 1968, Journal of pharmaceutical sciences.

[11]  M. L. La Rotonda,et al.  Interactions of nonsteroidal antiinflammatory drugs with phospholipids: comparison between octanol/buffer partition coefficients and chromatographic indexes on immobilized artificial membranes. , 1997, Journal of pharmaceutical sciences.

[12]  W. Frishman Atenolol and Timolol, Two New Systemic β-Adrenoceptor Antagonists , 1982 .

[13]  S. Adams,et al.  The metabolism of ibuprofen. , 1973, Xenobiotica; the fate of foreign compounds in biological systems.

[14]  G Folkers,et al.  Review of theoretical passive drug absorption models: historical background, recent developments and limitations. , 1996, Pharmaceutica acta Helvetiae.

[15]  L Lemberger,et al.  Fluoxetine: clinical pharmacology and physiologic disposition. , 1985, The Journal of clinical psychiatry.

[16]  H. Breithaupt,et al.  Kinetics of allopurinol after single intravenous and oral doses , 2004, European Journal of Clinical Pharmacology.

[17]  Klaus-Jürgen Schaper Absorption of Ionizable Drugs: Nonlinear Dependence on log P, pKa and pH ‐ Quantitative Relationships , 1982 .

[18]  D. Leahy,et al.  Partition and distribution coefficients of solutes and drugs in brush border membrane vesicles. , 1993, Biochemical pharmacology.

[19]  T. Blaschke,et al.  Clinical Pharmacokinetics of Rifabutin , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  A. Avdeef,et al.  pH-metric log P. II: Refinement of partition coefficients and ionization constants of multiprotic substances. , 1993, Journal of pharmaceutical sciences.

[21]  T. Yue,et al.  Carvedilol-liposome interaction: evidence for strong association with the hydrophobic region of the lipid bilayers. , 1996, Biochimica et biophysica acta.

[22]  G. Amidon,et al.  Absorption potential: estimating the fraction absorbed for orally administered compounds. , 1985, Journal of pharmaceutical sciences.

[23]  Alex Avdeef,et al.  pH‐Metric log P. Part 1. Difference Plots for Determining Ion‐Pair Octanol‐Water Partition Coefficients of Multiprotic Substances , 1992 .

[24]  A. Avdeef,et al.  pH-Metric logP 10. Determination of Liposomal Membrane-Water Partition Coefficients of lonizable Drugs , 1998, Pharmaceutical Research.

[25]  D Mackay,et al.  A novel method for measuring membrane-water partition coefficients of hydrophobic organic chemicals: comparison with 1-octanol-water partitioning. , 1988, Journal of Pharmacy and Science.

[26]  Hans Lennernäs,et al.  Does Fluid Flow Across the Intestinal Mucosa Affect Quantitative Oral Drug Absorption? Is It Time for a Reevaluation? , 1995, Pharmaceutical Research.

[27]  Y. Thériault,et al.  NMR study of the interaction of beta-blockers with sonicated dimyristoylphosphatidylcholine liposomes in the presence of praseodymium cation. , 1989, Membrane biochemistry.

[28]  K. Goa,et al.  Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. , 1997, Drugs.